Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...
Prostate cancer overtook breast cancer as the most commonly diagnosed cancer in England earlier this year. NHS data examined ...
A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.
Discover Magazine on MSN
How Common Really Is Prostate Cancer and How Easy Is it to Get Tested?
Learn more about prostate cancer and why there is a debate over whether or not patients should get tested for it.
Outside prostate cancer, Truqap is FDA-approved with fulvestrant (Faslodex) for patients with hormone receptor-positive, HER2 ...
3don MSN
Side effects of consuming too much dairy: What happens when you overdo milk, cheese, and yoghurt
Dairy products offer nutrients but overconsumption poses health risks. Excessive intake can cause digestive upset, bloating, ...
Discover how rectal spacers revolutionize prostate cancer treatment by reducing side effects and enhancing radiation dose ...
A targeted drug combination delays advanced prostate cancer in men with specific DNA repair gene mutations. A large international study led by researchers at UCL has found that a new combination of dr ...
Two cancer experts go head to head, arguing the case for and against a targeted prostate cancer screening programme.
High profile politicians have thrown their weight behind calls to screen at-risk men for prostate cancer, but are potential ...
Novartis has shared detailed data showing its radioligand therapy Pluvicto could slow the progression of certain hormone-sensitive prostate cancers ahead of a planned application with the FDA. | ...
Watch parts 1, 2, and 3 of our conversation with Dr Collins.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback